-
Symbol
-
KALV on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.001 per share
-
Latest Disclosed Ownership
-
3.47M shares
-
Security Ownership
-
6.9%
Frazier Life Sciences Public Fund, L.P. ownership in KalVista Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (KALV)
2025-11-04 - Frazier Life Sciences Public Fund, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3.47M shares of KalVista Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (KALV).
This represents 6.9% percent ownership of the company.
In their previous filing dated 2025-08-20, Frazier Life Sciences Public Fund, L.P. had reported owning 2.4M shares, indicating an increase of 44.4% percent.